Ambulatory Series: Prostate Cancer Screening and Associated Controversies

episode

UConn IM Residency Podcast 🎙️ not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Planning Commission Meeting - Sep 17, 2026 1h 11m · 17 Sep 2026 · Leesburg Planning Commission

Heritage Commission - Sep 14, 2026 1h 57m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Historic District Review Committee - Sep 14, 2026 1h 36m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Report any issue

Source

Recorded23 Oct 2023

Publisheranchor.fm ↗

Handlerec:4889755

Show notes

Thank you for joining us, today we will be reviewing prostate cancer screening and potential benefits as well as any associated controversies. The main focus of our discussion today revolves around PSA, or prostate-specific antigen. Although treating prostate cancer at an early stage to avoid long-term consequences, including potential metastatic disease, is important, we must acknowledge that our screening tools are imperfect. We don’t want to diminish the importance of treating an aggressive prostate cancer, but simply want to highlight that screening should not be done without a thorough explanation between you and your patient. Author: Nickolas Coombs, DO Host/Editor: Rob Harmon, DO

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in